The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 04, 2016

Filed:

Feb. 19, 2013
Applicants:

Igm Biosciences, Inc., Mountain View, CA (US);

Board of Trustees of the Leland Stanford Jr. Univ, Stanford, CA (US);

Inventors:

Neelima M Bhat, Los Altos, CA (US);

Marcia M. Bieber, Los Altos, CA (US);

Nelson N. H. Teng, Hillsborough, CA (US);

Martin E. Sanders, Hillsborough, CA (US);

Assignee:

IGM BIOSCIENCES, INC., Santa Clara, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 39/00 (2006.01); C07K 16/28 (2006.01); A61K 31/475 (2006.01); A61K 31/704 (2006.01); A61K 38/50 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2896 (2013.01); A61K 31/475 (2013.01); A61K 31/704 (2013.01); A61K 38/50 (2013.01); A61K 39/3955 (2013.01); A61K 39/39558 (2013.01); C07K 16/28 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01);
Abstract

Compositions and methods for inducing cell membrane wounding, cell permeabilization and cell killing are provided. The composition comprises a polyvalent agent that binds to a highly expressed cell surface antigen present on the surface of a cell. Preferably, the cell surface antigen is associated with the cytoskeleton of the cell. A preferred polyvalent agent is an IgM, and enhanced cell wounding and killing can be provided by the addition of a crosslinking agent. At sublethal concentrations in vivo, the cell wounding antibodies permeabilize cells and dramatically enhance response to chemotherapeutic agents, even in patients refractory to the chemotherapeutic agents.


Find Patent Forward Citations

Loading…